A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
Saved in:
| Title: | A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. |
|---|---|
| Authors: | Tarpgaard, Line S.1 line.tarpgaard@rsyd.dk, Qvortrup, Camilla1, Nygård, Sune B.2,3, Nielsen, Signe L.2, Andersen, Diana R.1, Jensen, Niels Frank2, Stenvang, Jan2, Detlefsen, Sönke4, Brünner, Nils2, Pfeiffer, Per1 |
| Source: | BMC Cancer. 2/11/2016, Vol. 16, p1-5. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-016-2124-5 |
